At a glance
3
Finished Products
1
Therapy Areas
4+
Delivery Formats
C3-CURA™
Primary Platform
All ingredients
Ingredient · 11/14
Ingredient · 11/14L-Arginine
L-Arginine – guanidinium side chain
L-Arginine – guanidinium side chain
Market Landscape
The opportunity – and where the market falls short.
- 01Nitric oxide booster – vasodilation, blood flow, endothelial function
- 02Cardio & performance – circulation, stamina, oxygen delivery, recovery
- 03Metabolic role – nutrient transport and cellular function
- 04Multi-segment use – men's health, sports, general wellness
- 05Performance-led, capsule/tablet-heavy, branding-led competition
The Stabicon Edge
From market limitation to measurable transformation.
| Market Limitation | Stabicon Transformation | Impact |
|---|---|---|
| Narrow Positioning | Condition-Specific Positioning – ED, circulation, recovery, fatigue | Expansion into clinical and men's health |
| Limited Clinical Mapping | Targeted Therapeutic Applications | Relevance across cardiovascular and metabolic health |
| Format Limitations | Simple, Effective Tablet Delivery | Wider adoption |
| Compliance Challenges | Optimized Dosing & Delivery | Better adherence |
| Low Differentiation | Sustained Release Technology | Prolonged action and differentiation |
| Missed Segments | Expanded Applications – aging, recovery, therapeutic use | Multi-segment portfolio |
Stabicon's Portfolio
L-Arginine reimagined across therapy areas and delivery formats.
3 finished formulations powered by L-Arginine, organised across 1 therapy category.
03
Products
01
Therapy Areas
04+
Formats
01 · Bladder • Liver • Recovery wellness
Translate